BioCentury
ARTICLE | Company News

CuraGen subsidiary names CEO

August 1, 2000 7:00 AM UTC

Drug discovery play CRGN hired M. Scott Salka as president and CEO of its 454 Corp. subsidiary (Branford, Conn.), which is developing genomic and proteomic technologies. Formerly, Salka was president ...